Rallybio Corporation (RLYB) Put/Call Volume History

Put/call volume ratio compares the number of put options traded to call options traded. Extreme readings can signal shifts in market sentiment relative to recent norms.

Rallybio Corporation (RLYB) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $77.0M, listed on NASDAQ, employing roughly 15 people, carrying a beta of -1.10 to the broader market. Rallybio Corporation, a clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases. Led by Stephen Uden, public since 2021-07-29.

Put/call volume history tracks trading activity and sentiment over time. No recent options activity for RLYB as of 2026-06-01; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options volume is reported and how to read the data →